/ /

CLINICAL

Spironolactone safe and effective for adult female acneMany dermatologists use spironolactone as a treatment in conjunction with traditional therapies, birth control and other hormonal modalities to help with the hormonal component of acne in adult women.
A tiered approach to managing acneThe goal of a tiered approach to acne is to improve both the patient’s acne and quality of life, while promoting responsible use of antibiotics.
Treating acne vulgaris in skin of colorThe clinical presentation of acne vulgaris in darker-skinned individuals differs in many ways from the white population, including some specific exacerbating factors that are due to cultural skin and hair-care practices.
Top 3 atopic dermatitis articles
Top 3 atopic dermatitis articlesAtopic dermatitis (AD) is one of the most common skin conditions treated by dermatologists. As such, articles on atopic dermatitis tend to be some of the most popular Dermatology Times content. These are the top three AD articles.
Phase 3 trials for acne treatment show promising resultsThe tetracycline-derived antibiotic sarecycline from Allergan plc and Paratek Pharmaceuticals Inc. for the treatment of moderate-to-severe acne has been found effective and safe, according to the results of two phase 3 trials.
Treating eczemas in skin of colorWhen it comes to treating atopic dermatitis in non-white racial ethnic groups, there are variations in prevalence, genetic factors and clinical presentation.
AD, skin microbes intertwinedAtopic dermatitis leads to Staphylococcus aureus colonization, one expert says.
June Clinical Considerations for NPs, PAsThis month, our clinical considerations include articles on the role of the microbe in acne, data around a topical agent to treat tinea pedis, and insights on sebum interacts with airborne pollution.
Biologic class differentiatorsDermatology experts offer insight into differentiating factors among TNF-alpha inhibitors, the IL 12/23 antagonist, IL 17 inhibitors and an oral option that carry considerations for managing certain patients.
A peek at the pipelineThere is tremendous excitement surrounding IL-23 inhibitors for the treatment of psoriasis. Three are currently in the pipeline.

Poll

View Results